BeOne Medicines Investor Relations Material
Latest events
Status Update
BeOne Medicines
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BeOne Medicines Ltd
Access all reports
BeiGene Ltd. is a biotechnology company focused on the discovery, development, and commercialization of innovative oncology treatments. Established in 2010, BeiGene has expanded its operations globally, with a significant presence in markets including the United States, China, Europe, and Australia. The company's product portfolio includes a range of treatments targeting various cancers such as blood cancers, solid tumors, and myelodysplastic syndromes. BeiGene is also actively involved in collaborative projects with other pharmaceutical companies to enhance its research and development capabilities. The company is headquartered in Grand Cayman, Cayman Islands, and its shares are listed on the NASDAQ.
Key slides for BeOne Medicines Ltd
Status Update
BeOne Medicines Ltd
Status Update
BeOne Medicines Ltd
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ONC
Country
🇺🇸 United States